Abstract:INTRODUCTION: The molecular underpinnings of the dissociation of cognitive performance and neuropathological burden are poorly understood, and there are currently no known genetic or epigenetic determinants of the dissociation.METHODS AND FINDINGS: "Residual cognition" was quantified by regressing out the effects of cerebral pathologies and demographic characteristics on global cognitive performance proximate to death. To identify genes influencing residual cognition, we leveraged neuropathological, genetic, epigenetic, and transcriptional data available for deceased participants of the Religious Orders Study (n = 492) and the Rush Memory and Aging Project (n = 487). Given that our sample size was underpowered to detect genome-wide significance, we applied a multistep approach to identify genes influencing residual cognition, based on our prior observation that independent genetic and epigenetic risk factors can converge on the same locus. In the first step (n = 979), we performed a genome-wide association study with a predefined suggestive p < 10-5, and nine independent loci met this threshold in eight distinct chromosomal regions. Three of the six genes within 100 kb of the lead SNP are expressed in the dorsolateral prefrontal cortex (DLPFC): UNC5C, ENC1, and TMEM106B. In the second step, in the subset of participants with DLPFC DNA methylation data (n = 648), we found that residual cognition was related to differential DNA methylation of UNC5C and ENC1 (false discovery rate < 0.05). In the third step, in the subset of participants with DLPFC RNA sequencing data (n = 469), brain transcription levels of UNC5C and ENC1 were evaluated for their association with residual cognition: RNA levels of both UNC5C (estimated effect = -0.40, 95% CI -0.69 to -0.10, p = 0.0089) and ENC1 (estimated effect = 0.0064, 95% CI 0.0033 to 0.0096, p = 5.7 × 10-5) were associated with residual cognition. In secondary analyses, we explored the mechanism of these associations and found that ENC1 may be related to the previously documented effect of depression on cognitive decline, while UNC5C may alter the composition of presynaptic terminals. Of note, the TMEM106B allele identified in the first step as being associated with better residual cognition is in strong linkage disequilibrium with rs1990622A (r2 = 0.66), a previously identified protective allele for TDP-43 proteinopathy. Limitations include the small sample size for the genetic analysis, which was underpowered to detect genome-wide significance, the evaluation being limited to a single cortical region for epigenetic and transcriptomic data, and the use of categorical measures for certain non-amyloid-plaque, non-neurofibrillary-tangle neuropathologies.CONCLUSIONS: Through a multistep analysis of cognitive, neuropathological, genomic, epigenomic, and transcriptomic data, we identified ENC1 and UNC5C as genes with convergent genetic, epigenetic, and transcriptomic evidence supporting a potential role in the dissociation of cognition and neuropathology in an aging population, and we expanded our understanding of the TMEM106B haplotype that is protective against TDP-43 proteinopathy.

Genetics of transient amnesia highlights a vascular role in memory

Calmodulin Shuttling Mediates Cytonuclear Signaling to Trigger Experience-Dependent Transcription and Memory

Forgetting the Unforgettable: Transient Global Amnesia Part I: Pathophysiology and Etiology

Multi-level Genomic Analyses Suggest New Genetic Variants Involved in Human Memory

Factors determining recurrence in transient global amnesia

[Genome-wide association study with memory measures as a quantitative trait locus for schizophrenia].

Genome-wide meta-analyses reveal novel loci for verbal short-term memory and learning

The link between reversible cerebral vasoconstriction syndrome and transient global amnesia

Network localization of transient global amnesia beyond the hippocampus

Selective vulnerability and resilience to Alzheimer’s disease tauopathy as a function of genes and the connectome

Transient global amnesia in legal proceedings

Rare genetic coding variants associated with age-related episodic memory decline implicate distinct memory pathologies in the hippocampus

Cerebral Small Vessel Disease Burden in Patients with Transient Global Amnesia and its Relationship with Recurrence

A Thalamic Orphan Receptor Drives Variability in Short-Term Memory

Clinical Course and Recurrence in Transient Global Amnesia: A Study From the TEMPiS Telestroke Network

Transient Global Amnesia Following Neural and Cardiac Angiography May Be Related to Ischemia

A systems biology-based identification and in vivo functional screening of Alzheimer's disease risk genes reveal modulators of memory function

Transient Global Amnesia: A Diffusion and Perfusion MRI study

Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data

Transient global amnesia - hippocampal lesions in magnetic resonance imaging

Abstract TP281: Ischemic Stroke Risk in Transient Global Amnesia